Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05188170
What this trial is testing

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Stanford University 16
Testing effectiveness (Phase 2)UnknownNCT04913922
What this trial is testing

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

Who this might be right for
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07761702
What this trial is testing

Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AML

Who this might be right for
AML (Acute Myelogenous Leukemia)
Shanghai Jiao Tong University School of Medicine 132
Testing effectiveness (Phase 2)Study completedNCT04230239
What this trial is testing

Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia

Who this might be right for
Newly Diagnosed Secondary or High Risk AML
PETHEMA Foundation 59
Testing effectiveness (Phase 2)Ended earlyNCT02712905
What this trial is testing

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 116
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT00055653
What this trial is testing

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817241
What this trial is testing

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00903422
What this trial is testing

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

Who this might be right for
Myelodysplastic Syndrome
GlaxoSmithKline 98
Testing effectiveness (Phase 2)Study completedNCT03030612
What this trial is testing

ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
OncoVerity, Inc. 38
Early research (Phase 1)Study completedNCT00093600
What this trial is testing

PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)Looking for participantsNCT06917911
What this trial is testing

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Who this might be right for
Core Binding Factor Acute Myeloid Leukemia
National Cancer Institute (NCI) 162
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT01503541
What this trial is testing

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin

Who this might be right for
Leukemia
SWOG Cancer Research Network 365
Early research (Phase 1)Study completedNCT03813186
What this trial is testing

Effect of Food on Blood Levels of ASTX727

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Astex Pharmaceuticals, Inc. 18
Not applicableLooking for participantsNCT06513273
What this trial is testing

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

Who this might be right for
Acute Myeloid LeukemiaAML, AdultAcute Myeloid Leukemia, Adult
Gruppo Italiano Malattie EMatologiche dell'Adulto 397
Testing effectiveness (Phase 2)Looking for participantsNCT07228273
What this trial is testing

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
OHSU Knight Cancer Institute 102
Early research (Phase 1)Study completedNCT00357305
What this trial is testing

Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Looking for participantsNCT07238712
What this trial is testing

Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

Who this might be right for
Acute Myeloid Leukemia (AML)Chronic Myeloid LeukemiaMyelodysplastic Syndromes (MDS)+2 more
St. Petersburg State Pavlov Medical University 60
Testing effectiveness (Phase 2)Study completedNCT02768792
What this trial is testing

High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia, in Relapse
UNC Lineberger Comprehensive Cancer Center 38
Next Page